Literature DB >> 10771815

Clinical profile of sickle cell disease in Orissa.

B C Kar1, S Devi.   

Abstract

Children comprised 52% of patients with Sickle Cell Disease (SCD). Types of Sickle Cell Disease encountered were SS (92.7%). SB thalassaemia (6.7%) and SD disease (0.7%). The disease was widespread in almost all castes and communities in the society; largest number of patients (20%) belonging to scheduled castes and only 1.4% were from scheduled tribes. Maximum number of cases were in the age group 2-4 and 4-6 years, many of whom died around this age. Besides attacks of pain, jaundice and anemia, frequent attacks of fever with anemia or only anemia in childhood were a predominant presenting feature. Splenic sequestration was frequent (10.1%). The patients usually had a steady state hemoglobin level of 6-10 g/dl, with which they thrived well. Fetal hemoglobin was 5-30%. Blood transfusion was not a frequent requirement, but prophylactic long acting penicillin was helpful in preventing frequency of crisis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10771815     DOI: 10.1007/bf02795780

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

1.  Sickle cell disease in Orissa State, India.

Authors:  B C Kar; R K Satapathy; A E Kulozik; M Kulozik; S Sirr; B E Serjeant; G R Serjeant
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

2.  Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation.

Authors:  A E Kulozik; J S Wainscoat; G R Serjeant; B C Kar; B Al-Awamy; G J Essan; A G Falusi; S K Haque; A M Hilali; S Kate
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

3.  The sickle cell gene is widespread in India.

Authors:  B C Kar; S Devi; K C Dash; M Das
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

4.  Sickle cell-beta+ thalassaemia in Orissa State, India.

Authors:  A E Kulozik; S Bail; B C Kar; B E Serjeant; G E Serjeant
Journal:  Br J Haematol       Date:  1991-02       Impact factor: 6.998

5.  Sickle cell disease in India.

Authors:  B C Kar
Journal:  J Assoc Physicians India       Date:  1991-12
  5 in total
  7 in total

1.  Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.

Authors:  Ravindra Kumar; Inusha Panigrahi; Ashwin Dalal; Sarita Agarwal
Journal:  Indian J Pediatr       Date:  2011-06-29       Impact factor: 1.967

2.  The screening and morbidity pattern of sickle cell anemia in chhattisgarh.

Authors:  Sumanta Panigrahi; P K Patra; P K Khodiar
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-13       Impact factor: 0.900

3.  Spectrum of Sickle Cell Diseases in Patients Diagnosed at a Tertiary Care Centre in Karnataka with Special Emphasis on their Clinicohaematological Profile.

Authors:  Hemalata Lokanatha; Pradeep Rudramurthy; Rajashekar Murthy G Ramachandrappa
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 4.  Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action.

Authors:  Vineet Raman; Prashanth N Srinivas; Tanya Seshadri; Sangeetha V Joice
Journal:  BMJ Glob Health       Date:  2021-02

5.  Sickle cell disease in India: A perspective.

Authors:  Graham R Serjeant; Kanjaksha Ghosh; Jyotish Patel
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

Review 6.  Evolving locally appropriate models of care for indian sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

7.  Homozygous sickle cell disease in Central India & Jamaica: A comparison of newborn cohorts.

Authors:  Dipty Jain; Rajini Tokalwar; Dipti Upadhye; Roshan Colah; Graham Roger Serjeant
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.